<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="100922">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02029859</url>
  </required_header>
  <id_info>
    <org_study_id>2009/070/HP</org_study_id>
    <nct_id>NCT02029859</nct_id>
  </id_info>
  <brief_title>Sleep Apnea, Obesity and Pregnancy</brief_title>
  <acronym>GOS</acronym>
  <official_title>Sleep Apnea, Obesity and Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Main objective:

      Determine the prevalence of obstructive sleep apnea syndrome (OSA) in late pregnancy in a
      population of obese patients .

      Secondary objectives :

        -  Identify risk factors for OSA during pregnancy (age, parity, high blood pressure,
           snoring , weight, neck circumference, scores on symptoms of sleep apnea, ... ) .

        -  Compare perinatal morbidity among obese patients with OSA in late pregnancy with
           case-controls.

        -  Evaluate the evolution of a moderate or severe OSA 6 months after pregnancy.

      Material and methods

      Characteristics of the study:

        -  Interventional biomedical research

        -  Prospective Multicenter nonrandomized study

      Flow chart

        -  Patients will be included between 30 and 36 weeks of amenorrhea (WA) .

        -  Will rated from inclusion: age, parity, weight, height, BMI in early pregnancy, neck
           circumferrence, treated high blood pressure.

        -  As recommended in France, the main test results during the pregnancy follow-up will be
           recorded.

        -  At the inclusion visit will be conducted a Berlin Questionnaire and Epworth Score.

        -  Screening for OSA by nocturnal polysomnography will be performed between 30 and 36WA.
           This screening can be performed as an outpatient.

        -  In case of proven OSA patients will be offered an appropriate care by today's
           standards.

        -  Whatever the outcome of pregnancy, a second polysomnography will be performed 6 months
           after childbirth in case of OSA during pregnancy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Sleep apnea syndrom prevalence</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Polygraphic examination for all subjects will determine the sleep apnea syndrom prevalence during late pregnancy (after 30 weeks of amenorhea) for severe obese women (BMI&gt;35).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">195</enrollment>
  <condition>Obesity</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Prevalence of obstructive sleep apnea syndrome</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Determine the prevalence of obstructive sleep apnea syndrome (OSA) in late pregnancy in a population of obese patients .
Polygraphic examination between 30 and 36 weeks of amenorhea</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Polygraphic examination</intervention_name>
    <description>Polygraphic examination between 30 and 36 weeks of amenorhea</description>
    <arm_group_label>Prevalence of obstructive sleep apnea syndrome</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &gt;35

          -  Pregnancy after 30 Weeks of amenorhea

          -  Age &gt; 18

          -  Signed consentment

          -  Nationnal Health Program affiliation

        Exclusion Criteria:

          -  Twin or more pregnancy

          -  Imprecise term

          -  Artificial insemination with donor gametes

          -  Proved thrombophilia

          -  chronic renal failure

          -  Previously treated (with CPAP) obstructive sleep apnea syndrom
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Loic Marpeau, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rouen University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stephane Oden, MHD</last_name>
    <phone>+33662781271</phone>
    <email>stephane.oden@chu-rouen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Loic Marpeau, PHD</last_name>
    <phone>+33232888990</phone>
    <email>loic.marpeau@chu-rouen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Angers University Hospital</name>
      <address>
        <city>Angers</city>
        <zip>49000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-Emmanuel Bouet, MHD</last_name>
    </contact>
    <investigator>
      <last_name>Loic Sentilhes, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre-Emmanuel Bouet, MHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frédéric GAGNADOUX</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascaline Priou</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Caen University Hospital</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Dolley, MHD</last_name>
    </contact>
    <investigator>
      <last_name>Michel Dreyfus, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Noël Prevost</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Le Havre Hospital</name>
      <address>
        <city>Le Havre</city>
        <zip>76290</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alain Talbot</last_name>
      <phone>+332 32 73 33 15</phone>
      <email>alain.talbot@ch-havre.fr</email>
    </contact>
    <investigator>
      <last_name>Alain Talbot</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean Quieffin</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rouen University Hospital</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephane Oden, MHD</last_name>
      <phone>+33662781271</phone>
      <email>stephane.oden@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>Loïc Marpeau, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphane Oden, MHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-François Muir, PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine Tardiff</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 10, 2014</lastchanged_date>
  <firstreceived_date>January 6, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pregnancy (after 30 weeks of amenorhea)</keyword>
  <keyword>obesity  (BMI&gt;35)</keyword>
  <keyword>sleep apnea syndrom</keyword>
  <keyword>preeclampsy</keyword>
  <keyword>intrauterine growth restriction</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
